Bammel A, van der Mee K, Ohnhaus E E, Kirch W
I. Medizinische Klinik, Christian-Albrechts-Universität, Kiel, FRG.
Eur J Clin Pharmacol. 1992;42(6):641-4. doi: 10.1007/BF00265929.
The effects of three different enzyme-inducing drugs (antipyrine 1200 mg, phenobarbital 100 mg, rifampicin 600 mg per day for 7 days) on plasma and urinary testosterone concentrations, plasma gonadotropin levels, antipyrine kinetics, and urinary 6 beta-hydroxycortisol excretion were studied in 18 healthy volunteers. Changes in plasma and urinary testosterone concentrations following exogenous testosterone undecanoate (TU) were also investigated. Although both antipyrine and rifampicin increased antipyrine clearance by about 60%, they produced contrary effects on testosterone: antipyrine lowered the total morning plasma testosterone and plasma testosterone AUC following TU, while rifampicin led to increases of about 20% and 78%, respectively. By contrast, phenobarbital did not significantly alter the endogenous and exogenous plasma testosterone concentrations, but it increased the urinary excretion of testosterone by more than 60%. The other two enzyme inducers did not alter this parameter. Gonadotropin levels remained unchanged. The results indicate that different enzyme-inducing agents exert divergent effects on endogenous and exogenous testosterone concentrations and suggest that the effect of enzyme induction on endogenous testosterone depends on the type of microsomal enzyme-inducing drug used rather than on the extent of the induction achieved.
在18名健康志愿者中研究了三种不同的酶诱导药物(安替比林1200毫克、苯巴比妥100毫克、利福平600毫克,每日一次,共7天)对血浆和尿睾酮浓度、血浆促性腺激素水平、安替比林动力学以及尿6β-羟基皮质醇排泄的影响。还研究了外源性十一酸睾酮(TU)后血浆和尿睾酮浓度的变化。虽然安替比林和利福平均使安替比林清除率增加约60%,但它们对睾酮产生相反的影响:安替比林降低了TU后早晨血浆总睾酮和血浆睾酮曲线下面积(AUC),而利福平则分别导致约20%和78%的增加。相比之下,苯巴比妥并未显著改变内源性和外源性血浆睾酮浓度,但它使睾酮尿排泄增加了60%以上。其他两种酶诱导剂未改变该参数。促性腺激素水平保持不变。结果表明,不同的酶诱导剂对内源性和外源性睾酮浓度产生不同的影响,并提示酶诱导对内源性睾酮的影响取决于所使用的微粒体酶诱导药物的类型,而非诱导程度。